Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$966M |
| 2 |
Verizon
VZ
|
+$445M |
| 3 |
ExxonMobil
XOM
|
+$409M |
| 4 |
Cencora
COR
|
+$269M |
| 5 |
ZTO Express
ZTO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$341M |
| 2 |
Avantor
AVTR
|
+$318M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$253M |
| 4 |
Salesforce
CRM
|
+$249M |
| 5 |
HCA Healthcare
HCA
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Healthcare | 13.37% |
| 3 | Financials | 12.68% |
| 4 | Industrials | 10.6% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEI
3801
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $74K | ﹤0.01% |
22,107
+4,298
| +24% | +$28.3K |
|
3802
Porch Group
PRCH
$1.58B
| $73K | ﹤0.01% |
28,706
-4,016
| -12% | -$16.6K |
|
3803
Playboy Inc
PLBY
$131M
| $71K | ﹤0.01% |
11,156
-901
| -7% | -$8.26K |
|
|
URG
3804
Ur-Energy
URG
$489M
| $71K | ﹤0.01% |
66,892
+4,441
| +7% | +$5.93K |
|
|
AAIC
3805
DELISTED
Arlington Asset Investment Corp.
AAIC
| $70K | ﹤0.01% |
21,437
-1,493
| -7% | -$4.98K |
|
3806
Angi Inc
ANGI
$222M
| $69K | ﹤0.01% |
+1,507
| New | +$74K |
|
|
GTYH
3807
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $68K | ﹤0.01% |
+10,882
| New | +$55.6K |
|
|
CMRX
3808
DELISTED
Chimerix, Inc.
CMRX
| $66K | ﹤0.01% |
31,853
-42
| -0.1% | -$135 |
|
|
AKTS
3809
DELISTED
Akoustis Technologies Inc
AKTS
| $66K | ﹤0.01% |
17,831
-1,495
| -8% | -$6.62K |
|
|
SNCE
3810
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $64K | ﹤0.01% |
+1,583
| New | +$116K |
|
3811
Humacyte
HUMA
$178M
| $63K | ﹤0.01% |
+19,267
| New | +$107K |
|
3812
Immunovant
IMVT
$7.85B
| $63K | ﹤0.01% |
16,243
-2,457
| -13% | -$10.6K |
|
3813
NextNav
NN
$1.8B
| $62K | ﹤0.01% |
+27,111
| New | +$130K |
|
3814
Roivant Sciences
ROIV
$24.3B
| $62K | ﹤0.01% |
+15,189
| New | +$60.3K |
|
|
OMIC
3815
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $62K | ﹤0.01% |
+539
| New | +$63.2K |
|
3816
Absci
ABSI
$1.29B
| $60K | ﹤0.01% |
17,997
+6,537
| +57% | +$32.5K |
|
3817
Dakota Gold
DC
$599M
| $60K | ﹤0.01% |
+17,957
| New | +$71.7K |
|
3818
Zeta Global
ZETA
$5.34B
| $60K | ﹤0.01% |
+13,201
| New | +$116K |
|
3819
VistaGen Therapeutics
VTGN
$10.1M
| $59K | ﹤0.01% |
2,244
+55
| +3% | +$1.94K |
|
|
TGAN
3820
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $59K | ﹤0.01% |
+15,336
| New | +$97.9K |
|
3821
Inseego
INSG
$113M
| $58K | ﹤0.01% |
3,060
-909
| -23% | -$23.2K |
|
3822
Ultrapar
UGP
$6.9B
| $58K | ﹤0.01% |
24,588
+5,937
| +32% | +$16.2K |
|
3823
Precigen
PGEN
$2.15B
| $57K | ﹤0.01% |
42,391
-2,182
| -5% | -$3.24K |
|
3824
Fulcrum Therapeutics
FULC
$239M
| $55K | ﹤0.01% |
11,100
-212,360
| -95% | -$2.08M |
|
|
ADTH
3825
DELISTED
AdTheorent Holding Co
ADTH
| $54K | ﹤0.01% |
+17,285
| New | +$130K |
|
Similar funds
Invesco's Q2 2022 Portfolio in Review
As of Q2 2022, Invesco held 4,260 positions worth $330B, down 16% from $392B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Invesco's Q2 2022 filing shows 250 new, 2,115 increased, 1,487 reduced and 228 closed positions. Its largest new stake was Heliogen, Inc.: 258,718 shares worth $19.1M. The largest sale was Qualcomm, an estimated $341M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q2 2022 buy was Heliogen, Inc.: 258,718 shares worth $19.1M.
- Invesco added most to HEICO Corp Class A in Q2 2022, an estimated $966M increase.
- Invesco's biggest Q2 2022 reduction was Qualcomm, cutting an estimated $341M.
- Invesco fully exited Cerner Corp in Q2 2022, selling an estimated $153M.
- Invesco's ten largest holdings make up 11% of its $330B portfolio in Q2 2022.
- Invesco opened 250 new positions and closed 228 in Q2 2022.
- Invesco's portfolio value fell 16% quarter-over-quarter to $330B.
Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.